Olena Bondarenko, MBA, Cpa, Cpim
About Olena Bondarenko, MBA, Cpa, Cpim
Olena Bondarenko, MBA, CPA, CPIM, is the Associate Director of Cell Therapy Operations Finance at Bristol Myers Squibb in New Brunswick, New Jersey.
Current Role at Bristol Myers Squibb
Olena Bondarenko currently holds the position of Associate Director, Cell Therapy Operations Finance at Bristol Myers Squibb. She joined the company in October 2021 and is based in New Brunswick, New Jersey, United States. Her role involves overseeing financial operations specific to cell therapy within the company.
Experience at Eli Lilly and Company
From 2017 to 2021, Olena Bondarenko worked at Eli Lilly and Company as the Associate Director of Manufacturing Finance. During her tenure, she was responsible for managing and overseeing the financial operations related to manufacturing. This position allowed her to deepen her expertise in pharmaceutical finance and manufacturing processes.
Role at Ortho Clinical Diagnostics
Olena Bondarenko was employed as a Senior Financial Analyst at Ortho Clinical Diagnostics from 2016 to 2017. Stationed at the Raritan plant in New Jersey, she focused on financial analysis for operations. Her work there played a significant role in the financial monitoring and assessment of the plant’s operational finances.
Auditing Experience at KPMG
Olena Bondarenko has a robust background in auditing, having worked at KPMG from 2013 to 2016. She started as an Audit Associate and progressed to Senior Audit Associate in Short Hills, New Jersey. Over this period, she gained valuable experience in auditing practices, which have contributed to her expertise in financial analysis and operational finance.
Education and Professional Certifications
Olena Bondarenko holds an MBA and is a Certified Public Accountant (CPA). In addition to these qualifications, she is also a Certified in Production and Inventory Management (CPIM). These credentials showcase her extensive knowledge and capability in finance, accounting, and inventory management within the manufacturing sector.